Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.04%) to 10680.59, DAX (0.02%) to 24986.25, CAC40 +0.26% to 8519.21, STOXX 600 +0.23% to 629.14

Feb 24 ,2026

  • Synopsis:

    • European equity markets ended mixed Tuesday, off earlier weaker levels. Regional outperformers included Swiss SMI +0.9% and OMX Stockholm +0.8%, while notable decliners were Austria ATX (1.6%) and OMX Copenhagen (1.4%). Crude lower ahead of US-Iran nuclear talks due later this week; WTI Crude (0.32%) to $66.10. Precious metals were mixed; Gold (1.28%) to $5158.80. Copper higher as China returned from LNY holiday. Bitcoin below level on day President Trump was re-elected.

    • US equities were higher Tuesday. Software bounce (though off best levels) seemingly the big story with some semblance of reprieve surrounding Anthropic enterprise agent event, where takeaways have focused on partnerships. Also plenty of pushback (though not new) against some of the more dire industry and macro takeaways from the Citrini report that acted as a big overhang on risk sentiment on Monday. However, stabilization still seen as precarious and not driving a broader risk-on move. Semis another bright spot on AMD compute deal with META and expectations for another strong Q and guidance out of NVDA tomorrow after the close. In the US, ADP weekly private payrolls of 12.75K per week a fourth-straight increase, highest since Nov. December FHFA home price index was up 0.1% m/m, while Case-Shiller 20-city index rose 0.5%. Conference Board consumer confidence and wholesale inventories coming later this morning. A bit of Fedspeak today. Chicago's Goolsbee said inflation progress has stalled and said it is not obvious rate policy is even restrictive. Atlanta's Bostic cautioned Fed may not be able to offset structural pressures on employment via interest rates. Waller, Collins, Cook spoke on technology. In addition, President Trump to give the SOTU address this evening. Trump expected to talk up the economy and highlight new affordability measures.

    • In Europe, EU postponed ratification of trade agreement with US, citing insufficient clarity from US administration on intentions - a delay that leaves EU exports subject to 15% tariffs for now. Comes as Trump warned countries stepping back from trade deals risk worse terms. In geopolitics, today marks four years since Russia's invasion of Ukraine, with conflict showing no signs of near-term resolution. Slovakia's decision to halt emergency electricity supplies to Ukraine - pending resolution of disputed Druzhba pipeline - adds further layer of European energy uncertainty. On the macro front, France manufacturing confidence missed expectations. BoE's Bailey said March rate cut is 'genuinely open question'.

    • European sectors closed higher across the board, led by Autos & Parts (ACEA data, Forvia (FRVIA.FP) results and strategic roadmap) and Chemicals (Croda (CRDA.LN) and Solvay (SOLB.BB) up on results) while Banks clearly bucked the trend (Standard Chartered (STAN.LN) lower on results/guidance). In healthcare space, Fresenius Medical Care (FME.GR) Q4 beat but shares fell on soft 2026 revenue guidance and cautious medium-term outlook. Novo Nordisk (NOVO.B.DC) confirmed significant reduction in US list price for Wegovy, Ozempic, and Rybelsus (semaglutide medicines)

    • Looking ahead to tomorrow's session, another busy day for earnings with the likes of Diageo (DGE.LN), E.ON (EOAN.GR), Bayer (BAYN.GR), Heidelberg Materials (HEI.GR), Iberdrola (IBE.SM), Bureau Veritas (BVI.FP) and Haleon (HLN.FP) reporting.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Autos & Parts +1.92%, Basic Resources +1.47%, Chemicals +1.41%, Utilities +1.34%, Retail +1.22%, Food & Beverage +1.20%, Travel & Leisure +0.76%, Technology +0.66%, Construct & Mtls +0.63%, Oil & Gas +0.49%, Real Estate +0.25%

      • Underperformers

        • Banks (1.29%), Media (0.37%), Financial Svcs (0.25%), Insurance +0.09%, Telecom +0.18%, Health Care +0.19%, Ind Goods & Svcs +0.21%, Persnl & HHold Goods +0.22%

    • Macro:

      • Autos

        • European Automobile Manufacturers' Association (ACEA) January new car registrations for EU + EFTA + UK (3.5%) y/y

      • Geopolitics

        • Hungary, Slovakia spar with Ukraine over Druzhba pipeline -- DW

      • UK

        • Bank of England's Bailey says March rate cut is 'genuinely open question' -- Reuters

        • Reform UK plans to use £500bn assets of council pensions to invest in British businesses -- FT

      • Norway

        • Norway Central Bank Seen Delaying Next Rate Cut to Third Quarter -- Bloomberg

      • Banks

        • ECB Touts Lighter Burden on Banks in Planned Underwriting Review -- Bloomberg

  • Company news:

    • Notable Gainers

      • +22.6% ALCOX.FP (Nicox €0.51, +0.09) -- study results

      • +17.3% PARRO.FP (Parrot €8.00, +1.18) -- Finnish defence forces to procure Parrot ANAFI UKR micro-UAV systems

      • +16.7% OERL.SW (OC Oerlikon Corp. CHF4.44, +0.63) -- FY earnings

      • +10.1% CTEC.LN (ConvaTec Group £2.50, +0.23) -- FY earnings

      • +9.6% ELG.GR (Elmos Semiconductor €139.80, +12.20) -- FY earnings

      • +8.7% F3C.GR (SFC Energy €13.98, +1.12) -- prelim FY earnings

      • +8.1% CRDA.LN (Croda International £32.28, +2.43) -- FY earnings

      • +8.0% MPCC.NO (MPC Container Ships NOK21.89, +1.63) -- Q4 earnings

      • +7.0% ELE.SM (Endesa €34.24, +2.23) -- CMD; FY earnings

      • +6.6% TENG.LN (Ten Lifestyle Group £0.73, +0.04) -- contract

      • +6.0% ILKKA2.FH (Ilkka Oyj €4.26, +0.24) -- Inderes upgrade

      • +6.0% AUSS.NO (Austevoll Seafood NOK99.00, +5.60) -- Q4 earnings

      • +5.1% SOLB.BB (Solvay €28.24, +1.38) -- Q4 earnings; optimizes soda ash capacity to strengthen competitiveness

      • +5.1% LSG.NO (Lerøy Seafood Group NOK50.50, +2.46) -- Q4 earnings

      • +4.5% EDEN.FP (Edenred €19.02, +0.82) -- FY earnings

      • +4.4% FRVIA.FP (Forvia €13.29, +0.56) -- CMD; FY earnings; updates on planned divestiture of Interiors Business Group; advanced negotiations underway with several parties

      • +4.4% GLPG.NA (Galapagos €29.66, +1.26) -- FY earnings

      • +4.1% DNORD.DC (D/S Norden DKK283.00, +11.20)

      • +3.7% BONEX.SS (BONESUPPORT HOLDING SEK187.40, +6.60) -- Q4 earnings

      • +3.5% CHG.LN (Chemring Group £5.28, +0.18) -- initiated buy at Peel Hunt

      • +3.4% ASHM.LN (Ashmore Group £2.47, +0.08) -- Jefferies upgrade

      • +3.0% ENH.NO (SED Energy Holdings NOK9.68, +0.28) -- Q4 earnings

      • +2.0% RNO.FP (Renault €32.65, +0.64) -- ACEA January numbers

      • +1.9% STLAM.IM (Stellantis €6.60, +0.12) -- ACEA January numbers

      • +1.5% CGEO.LN (Georgia Capital £34.25, +0.50) -- FY earnings

      • +1.2% PRS.SM (Promotora de Informaciones €0.35, -0.00) -- updates on the proposed restructuring operation

      • +0.2% LIGHT.NA (Signify €20.32, +0.04) -- appoints new Chair

    • Notable Decliners

      • -13.0% BBN.SW (Bellevue Group CHF9.44, -1.41) -- FY earnings

      • -12.9% IMMNOV.SS (Immunovia SEK0.17, -0.03) -- Q4 earnings

      • -12.8% UTG.LN (UNITE Group £5.04, -0.74) -- agrees sale of St Pancras Way to USAF for £186M; FY earnings

      • -12.4% OXB.LN (OXB £6.78, -0.96) -- FY trading update

      • -7.7% MCB.LN (McBride £1.54, -0.13) -- H1 eanrings

      • -7.3% WIE.AV (Wienerberger €28.30, -2.24) -- to acquire Italcer Group; confirms FY earnings

      • -7.2% FME.GR (Fresenius Medical Care €38.42, -2.97) -- Q4 earnings

      • -6.3% GALE.SW (Galenica CHF95.40, -6.40) -- announces Bichsel plans to discontinue its production division by the end of 2026; UBS downgrade

      • -6.3% MTX.GR (MTU Aero Engines €372.50, -25.00) -- Q4 earnings

      • -4.1% PAAL.B.DC (Per Aarsleff Holding DKK834.00, -36.00) -- Q1 eanrings

      • -3.5% DOKA0.SW (dormakaba Holding CHF58.00, -2.10) -- H1 earnings; acquires a stake in SwiftConnect Inc

      • -3.3% MAB1.LN (Mortgage Advice Bureau £6.48, -0.22)

      • -3.1% NOVO.B.DC (Novo Nordisk DKK243.65, -7.75) --

        • reportedly to lower US list prices for Ozempic, Wegovy by up to 50%, to take effect January 2027 - media report

        • JPMorgan, Kepler Cheuvreux and Nordea downgrades; study update

      • -2.7% RTO.LN (Rentokil Initial £4.47, -0.12) -- Deutsche Numis downgrade

      • -2.6% GXI.GR (Gerresheimer €18.64, -0.50) -- UBS downgrade

      • -2.2% NEX.FP (Nexans €120.20, -2.70) -- Nexans holder Invexans (Quiñenco/Luksic Group) reportedly plans to reduce stake by ~2.2M shares via bookbuilding offering - Bloomberg

  • EU companies reporting tomorrow:

    • Earnings:

      • Austria: EVN (EVN.AV)

      • Belgium: Ageas (AGS.BB), Deceuninck (DECB.BB), Cie d'Entreprises CFE (CFEB.BB)

      • Denmark: Novonesis (NSIS.B.DC), Sydbank (SYDB.DC), NKT (NKT.DC), North Media (NORTHM.DC), Møns Bank (MNBA.DC)

      • Finland: Oriola (ORIOLA.FH), Gofore (GOFORE.FH), Tecnotree (TEM1V.FH), Kamux (KAMUX.FH)

      • France: Eiffage (FGR.FP), Bureau Veritas (BVI.FP), SEB (SK.FP), OPmobility (OPM.FP), Interparfums (ITP.FP), Ipsos (IPS.FP), Fnac Darty (FNAC.FP), Nexity (NXI.FP), Worldline (WLN.FP)

      • Germany: E.ON (EOAN.GR), Bayer (BAYN.GR), Heidelberg Materials (HEI.GR), Fresenius (FRE.GR), Nordex (NDX1.GR), Auto1 Group (AG1.GR), Freenet (FNTN.GR), BRAIN Biotech (BNN.GR)

      • Italy: Leonardo (LDO.IM), Poste Italiane (PST.IM)

      • Netherlands: Wolters Kluwer (WKL.NA), Royal Vopak (VPK.NA), AMG Critical Materials (AMG.NA)

      • Norway: Odfjell Drilling (ODL.NO), Höegh Autoliners (HAUTO.NO), Grieg Seafood (GSF.NO), Panoro Energy (PEN.NO), Integrated Wind Solutions (IWS.NO), Nykode Therapeutics (NYKD.NO), Saga Pure (SAGA.NO), Vow (VOW.NO)

      • Portugal: Banco Comercial Portugues (BCP.PL)

      • Spain: Iberdrola (IBE.SM), Ferrovial (FER.SM), Aena (AENA.SM), ACS (ACS.SM), Indra Sistemas (IDR.SM), Laboratorios Farmaceuticos Rovi (ROVI.SM), Vidrala (VID.SM), Neinor Homes (HOME.SM)

      • Sweden: Better Collective (BETCO.SS), Samhällsbyggnadsbolaget i Norden (SBB.B.SS), Greater Than (GREAT.SS), IRLAB Therapeutics (IRLAB.A.SS)

      • Switzerland: Adecco Group (ADEN.SW), Sandoz Group (SDZ.SW), Georg Fischer (GF.SW)

      • UK: Diageo (DGE.LN), Haleon (HLN.LN), St. James's Place (STJ.LN), Hiscox (HSX.LN), ConvaTec Group (CTEC.LN), Lion Finance Group (BGEO.LN), Shaftesbury Capital (SHC.LN), Morgan Sindall Group (MGNS.LN), Hammerson (HMSO.LN), Aston Martin Lagonda Global Holdings (AML.LN), International Personal Finance (IPF.LN), Avingtrans (AVG.LN), AFC Energy (AFC.LN)

      • Other: Magyar Telekom Telecommunications (MTEL.HB), Glanbia (GL9.ID)

    • Trading Update:

      • France: SEB (SK.FP), Bilendi (ALBLD.FP)

      • Southern Europe: Pirelli & C. (PIRC.IM)

    • CMD/Events: Banco Santander (SAN.SM), Temenos (TEMN.SW)

  • Data:

    • Economics:

      • France Feb Business Survey 102 vs consensus 104 and prior 105

      • Finland Jan Unemployment Rate 10.3% vs consensus 10.0% and prior 9.8%

    • Markets:

      • WTI Crude (Apr 26): ($0.30) or (0.45%) to $66.01

      • €-$ +0.0004 or +0.03% to 1.1790

      • £-$ +0.0037 or +0.27% to 1.3531

      • €-£ (0.0022) to 0.8712

      • S&P 500 +0.49%

      • Performance year-to-date

        • FTSE 100: +7.54%

        • DAX: +2.02%

        • CAC: +4.54%

        • MIB: +3.80%

        • Stoxx 600: +6.24%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE